{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:55:06Z","timestamp":1785790506058,"version":"3.56.0"},"reference-count":143,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100020582","name":"National Institute of Pharmaceutical Education and Research, Raebareli","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020582","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.actbio.2022.11.001","type":"journal-article","created":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T12:29:40Z","timestamp":1667651380000},"page":"57-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Immune cell\u2013camouflaged surface-engineered nanotherapeutics for cancer management"],"prefix":"10.1016","volume":"155","author":[{"given":"Naitik","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed","family":"Shahrukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paras","family":"Famta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Vambhurkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharmendra Kumar","family":"Khatri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashi Bala","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2022.11.001_bib0001","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.actbio.2022.11.001_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells10020389","article-title":"Impacts of environmental factors on head and neck cancer pathogenesis and progression","volume":"10","author":"Miranda-Galvis","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.actbio.2022.11.001_bib0003","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10689-021-00227-3","article-title":"Genetic predisposition to prostate cancer: an update","volume":"21","author":"Ni Raghallaigh","year":"2022","journal-title":"Fam. Cancer"},{"key":"10.1016\/j.actbio.2022.11.001_bib0004","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S2352-4642(20)30275-3","article-title":"Predisposition to cancer in children and adolescents","volume":"5","author":"Kratz","year":"2021","journal-title":"Lancet Child Adolesc. Heal."},{"key":"10.1016\/j.actbio.2022.11.001_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2019.00408","article-title":"Testicular cancer: genes, environment, hormones","volume":"10","author":"De Toni","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.actbio.2022.11.001_bib0006","doi-asserted-by":"crossref","first-page":"e00317","DOI":"10.14309\/ctg.0000000000000317","article-title":"Smoking, genetic predisposition, and colorectal cancer risk","volume":"12","author":"Chen","year":"2021","journal-title":"Clin. Transl. Gastroenterol."},{"key":"10.1016\/j.actbio.2022.11.001_bib0007","doi-asserted-by":"crossref","first-page":"6009","DOI":"10.21873\/anticanres.14622","article-title":"Role of oncogenes and tumor-suppressor genes in carcinogenesis: a review","volume":"40","author":"Kontomanolis","year":"2020","journal-title":"Anticancer Res."},{"key":"10.1016\/j.actbio.2022.11.001_bib0008","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1177\/1947601911408889","article-title":"Mutations in the p53 tumor suppressor gene: important milestones at the various steps of tumorigenesis","volume":"2","author":"Rivlin","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1016\/j.actbio.2022.11.001_bib0009","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA. Cancer J. Clin."},{"key":"10.1016\/j.actbio.2022.11.001_bib0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/aam.aam_56_18","article-title":"Inflammation and cancer","volume":"18","author":"Singh","year":"2019","journal-title":"Ann. Afr. Med."},{"key":"10.1016\/j.actbio.2022.11.001_bib0011","doi-asserted-by":"crossref","DOI":"10.1038\/npre.2010.4225.1","article-title":"Inflammation targets specific organs for cancer in carriers of BRCA1\/2 pathway mutations","author":"Friedenson","year":"2010","journal-title":"Nat. Preced."},{"key":"10.1016\/j.actbio.2022.11.001_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcell.2018.00056","article-title":"Underlying causes and therapeutic targeting of the inflammatory tumor microenvironment","volume":"6","author":"Comen","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.actbio.2022.11.001_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2022.864739","article-title":"Dual relationship between stromal cells and immune cells in the tumor microenvironment","volume":"13","author":"Mun","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actbio.2022.11.001_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3332\/ecancer.2017.721","article-title":"Dual role of inflammatory mediators in cancer","volume":"11","author":"Shrihari","year":"2017","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.actbio.2022.11.001_bib0015","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s12253-015-9913-z","article-title":"The role of the mediators of inflammation in cancer development","volume":"21","author":"Fernandes","year":"2015","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.actbio.2022.11.001_bib0016","first-page":"2516","article-title":"DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice","volume":"118","author":"Meira","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.actbio.2022.11.001_bib0017","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature24302","article-title":"Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity","volume":"551","author":"Shalapour","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.actbio.2022.11.001_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2019.01370","article-title":"Role of matrix metalloproteinases in angiogenesis and cancer","volume":"9","author":"Quintero-Fabi\u00e1n","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.actbio.2022.11.001_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21249739","article-title":"The roles of matrix metalloproteinases and their inhibitors in human diseases","volume":"21","author":"Cabral-Pacheco","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.actbio.2022.11.001_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2019.01399","article-title":"Contribution of angiogenesis to inflammation and cancer","volume":"9","author":"Aguilar-Cazares","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.actbio.2022.11.001_bib0021","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000443526","article-title":"1854-1915) and His contributions to the foundation and birth of translational medicine","volume":"8","author":"Valent","year":"2016","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.actbio.2022.11.001_bib0022","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.nantod.2015.06.006","article-title":"Nanoparticle uptake: the phagocyte problem","volume":"10","author":"Gustafson","year":"2015","journal-title":"Nano Today"},{"key":"10.1016\/j.actbio.2022.11.001_bib0023","doi-asserted-by":"crossref","first-page":"E10871","DOI":"10.1073\/pnas.1713390114","article-title":"Effect of removing Kupffer cells on nanoparticle tumor delivery","volume":"114","author":"Tavares","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.actbio.2022.11.001_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/adma.201604789","article-title":"Enhancing photodynamic therapy through resonance energy transfer constructed near-infrared photosensitized nanoparticles","volume":"29","author":"Huang","year":"2017","journal-title":"Adv. Mater."},{"key":"10.1016\/j.actbio.2022.11.001_bib0025","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nnano.2011.166","article-title":"Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size","volume":"6","author":"Cabral","year":"2011","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.actbio.2022.11.001_bib0026","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1021\/nl900031y","article-title":"Mediating tumor targeting efficiency of nanoparticles through design","volume":"9","author":"Perrault","year":"2009","journal-title":"Nano Lett."},{"key":"10.1016\/j.actbio.2022.11.001_bib0027","doi-asserted-by":"crossref","first-page":"392","DOI":"10.7150\/thno.13727","article-title":"Improving nanoparticle penetration in tumors by vascular disruption with acoustic droplet vaporization","volume":"6","author":"Ho","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.actbio.2022.11.001_bib0028","doi-asserted-by":"crossref","first-page":"8782","DOI":"10.1158\/1078-0432.CCR-05-1664","article-title":"The distribution of the anticancer drug doxorubicin in relation to blood vessels in solid tumors","volume":"11","author":"Primeau","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.actbio.2022.11.001_bib0029","first-page":"1703","article-title":"Doxorubicin gradients in human breast cancer","volume":"5","author":"Lankelma","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.actbio.2022.11.001_bib0030","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/jnci\/djm135","article-title":"Drug resistance and the solid tumor microenvironment","volume":"99","author":"Tr\u00e9dan","year":"2007","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.actbio.2022.11.001_bib0031","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.msec.2019.01.066","article-title":"Employment of enhanced permeability and retention effect (EPR): nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer","volume":"98","author":"Kalyane","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.actbio.2022.11.001_bib0032","doi-asserted-by":"crossref","first-page":"25047","DOI":"10.1039\/D1RA03671H","article-title":"Effects of macrophage polarization on gold nanoparticle-assisted plasmonic photothermal therapy","volume":"11","author":"Ali","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.actbio.2022.11.001_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119902","article-title":"Tumor extravasation and infiltration as barriers of nanomedicine for high efficacy: the current status and transcytosis strategy","volume":"240","author":"Zhou","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2022.11.001_bib0034","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jconrel.2014.03.057","article-title":"EPR: evidence and fallacy","volume":"190","author":"Nichols","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2022.11.001_bib0035","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26165052","article-title":"Advances in biomimetic nanoparticles for targeted cancer therapy and diagnosis","volume":"26","author":"Beh","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.actbio.2022.11.001_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101174","article-title":"Targeting immune cells for cancer therapy","volume":"25","author":"Gun","year":"2019","journal-title":"Redox. Biol."},{"key":"10.1016\/j.actbio.2022.11.001_bib0037","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.actbio.2022.11.001_bib0038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics12121222","article-title":"Neutrophils and macrophages as targets for development of nanotherapeutics in inflammatory diseases","volume":"12","author":"Su","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.actbio.2022.11.001_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2011.00098","article-title":"Chronic inflammation in cancer development","volume":"2","author":"Multhoff","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actbio.2022.11.001_bib0040","doi-asserted-by":"crossref","DOI":"10.1002\/EXP.20210171","article-title":"Engineered cancer cell membranes: an emerging agent for efficient cancer theranostics","volume":"2","author":"Guo","year":"2022","journal-title":"Exploration"},{"key":"10.1016\/j.actbio.2022.11.001_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2021.133848","article-title":"Biomimetic neutrophil and macrophage dual membrane-coated nanoplatform with orchestrated tumor-microenvironment responsive capability promotes therapeutic efficacy against glioma","volume":"433","author":"Yin","year":"2022","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.actbio.2022.11.001_bib0042","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells10010100","article-title":"Inflammatory cytokines in cancer: comprehensive understanding and clinical progress in gene therapy","volume":"10","author":"Lan","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.actbio.2022.11.001_bib0043","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nri1964","article-title":"Tuning inflammation and immunity by chemokine sequestration: decoys and more","volume":"6","author":"Mantovani","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.actbio.2022.11.001_bib0044","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1053\/j.gastro.2010.01.058","article-title":"Inflammation and colon cancer","volume":"138","author":"Terzi\u0107","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.actbio.2022.11.001_bib0045","doi-asserted-by":"crossref","first-page":"112132","DOI":"10.18632\/oncotarget.22792","article-title":"The regulation of pre-metastatic niche formation by neutrophils","volume":"8","author":"Jablonska","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.actbio.2022.11.001_bib0046","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.01749","article-title":"The Emerging Role of Neutrophil Extracellular Traps (NETs) in tumor progression and metastasis","volume":"11","author":"Masucci","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actbio.2022.11.001_bib0047","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.4049\/jimmunol.1201719","article-title":"Neutrophil extracellular traps: double-edged swords of innate immunity","volume":"189","author":"Kaplan","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.actbio.2022.11.001_bib0048","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216055","article-title":"Cancer cell\u2013induced neutrophil extracellular traps promote both hypercoagulability and cancer progression","volume":"14","author":"Jung","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.actbio.2022.11.001_bib0049","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag1711","article-title":"Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps","volume":"8","author":"Park","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.actbio.2022.11.001_bib0050","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13236131","article-title":"Neutrophil extracellular traps (Nets) in cancer metastasis","volume":"13","author":"Kaltenmeier","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.actbio.2022.11.001_bib0051","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1021\/acsnano.6b06477","article-title":"Nanoparticles coated with neutrophil membranes can effectively treat cancer metastasis","volume":"11","author":"Kang","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.actbio.2022.11.001_bib0052","doi-asserted-by":"crossref","first-page":"5792","DOI":"10.1038\/s41388-019-0840-4","article-title":"Promotion of tumor-associated macrophages infiltration by elevated neddylation pathway via NF-\u03baB-CCL2 signaling in lung cancer","volume":"38","author":"Zhou","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.actbio.2022.11.001_bib0053","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6248590","article-title":"Altered NKp30, NKp46, NKG2D, and DNAM-1 expression on circulating NK Cells is associated with tumor progression in human gastric cancer","volume":"2018","author":"Han","year":"2018","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.actbio.2022.11.001_bib0054","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20150207","article-title":"Applications of nanoparticles for diagnosis and therapy of cancer","volume":"88","author":"Baetke","year":"2015","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.actbio.2022.11.001_bib0055","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12951-020-00649-8","article-title":"Macrophage-cancer hybrid membrane-coated nanoparticles for targeting lung metastasis in breast cancer therapy","volume":"18","author":"Gong","year":"2020","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.actbio.2022.11.001_bib0056","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.apsb.2018.12.009","article-title":"Neutrophil-mimicking therapeutic nanoparticles for targeted chemotherapy of pancreatic carcinoma","volume":"9","author":"Cao","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.actbio.2022.11.001_bib0057","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.2147\/IJN.S288636","article-title":"Engineering of neutrophil membrane camouflaging nanoparticles realizes targeted drug delivery for amplified antitumor therapy","volume":"16","author":"Wang","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.actbio.2022.11.001_bib0058","article-title":"Saikosaponin D loaded macrophage membrane-biomimetic nanoparticles target angiogenic signaling for breast cancer therapy","volume":"18","author":"Sun","year":"2020","journal-title":"Appl. Mater. Today"},{"key":"10.1016\/j.actbio.2022.11.001_bib0059","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fbioe.2020.00943","article-title":"Melanoma peptide MHC specific TCR expressing T-cell membrane camouflaged PLGA nanoparticles for treatment of melanoma skin cancer","volume":"8","author":"Yaman","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.actbio.2022.11.001_bib0060","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201900251","article-title":"T cell membrane mimicking nanoparticles with bioorthogonal targeting and immune recognition for enhanced photothermal therapy","volume":"6","author":"Han","year":"2019","journal-title":"Adv. Sci."},{"key":"10.1016\/j.actbio.2022.11.001_bib0061","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-021-00805-8","article-title":"Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles","volume":"19","author":"Gong","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.actbio.2022.11.001_bib0062","doi-asserted-by":"crossref","first-page":"10854","DOI":"10.1039\/D0NR00523A","article-title":"Engineering macrophage-derived exosomes for targeted chemotherapy of triple-negative breast cancer","volume":"12","author":"Li","year":"2020","journal-title":"Nanoscale"},{"key":"10.1016\/j.actbio.2022.11.001_bib0063","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.3390\/pharmaceutics13101686","article-title":"Chitosan nanoparticles at the biological interface: implications for drug delivery","volume":"13","author":"Aibani","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.actbio.2022.11.001_bib0064","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1007\/s11095-014-1419-y","article-title":"Biomaterials for nanoparticle vaccine delivery systems","volume":"31","author":"Sahdev","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.actbio.2022.11.001_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118050","article-title":"Immunostimulatory effect of chitosan and quaternary chitosan: a review of potential vaccine adjuvants","volume":"264","author":"Li","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.actbio.2022.11.001_bib0066","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1021\/acsomega.9b03531","article-title":"Transmembrane TNF\u03b1-expressed macrophage membrane-coated chitosan nanoparticles as cancer therapeutics","volume":"5","author":"Bhattacharyya","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.actbio.2022.11.001_bib0067","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6528\/aaa7c7","article-title":"Macrophage membrane-coated iron oxide nanoparticles for enhanced photothermal tumor therapy","volume":"29","author":"Meng","year":"2018","journal-title":"Nanotechnology"},{"key":"10.1016\/j.actbio.2022.11.001_bib0068","doi-asserted-by":"crossref","unstructured":"F. Oroojalian, M. Beygi, B. Baradaran, A. Mokhtarzadeh, M.A. Shahbazi, Immune cell membrane-coated biomimetic nanoparticles for targeted cancer therapy, 2021. doi:10.1002\/smll.202006484.","DOI":"10.1002\/smll.202006484"},{"key":"10.1016\/j.actbio.2022.11.001_bib0069","doi-asserted-by":"crossref","unstructured":"F. Alexis, E. Pridgen, L.K. Molnar, O.C. Farokhzad, Factors affecting the clearance and biodistribution of polymeric nanoparticles, (n.d.). doi:10.1021\/mp800051m.","DOI":"10.1021\/mp800051m"},{"key":"10.1016\/j.actbio.2022.11.001_bib0070","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jconrel.2016.06.040","article-title":"Anti-PEG antibodies in the clinic: current issues and beyond PEGylation","volume":"244","author":"Zhang","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2022.11.001_bib0071","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-022-01251-w","article-title":"Nanocarriers surface engineered with cell membranes for cancer targeted chemotherapy","volume":"20","author":"Lei","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.actbio.2022.11.001_bib0072","doi-asserted-by":"crossref","first-page":"17080","DOI":"10.1021\/acsnano.1c03800","article-title":"Cell membrane-coated mimics: a methodological approach for fabrication, characterization for therapeutic applications, and challenges for clinical translation","volume":"15","author":"Chugh","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.actbio.2022.11.001_bib0073","article-title":"Membrane engineering of cell membrane biomimetic nanoparticles for nanoscale therapeutics","volume":"11","author":"Zhang","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.actbio.2022.11.001_bib0074","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/nm.2198","article-title":"Therapeutic cell engineering with surface-conjugated synthetic nanoparticles","volume":"16","author":"Stephan","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.actbio.2022.11.001_bib0075","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.7150\/thno.40291","article-title":"Coating biomimetic nanoparticles with chimeric antigen receptor T cell-membrane provides high specificity for hepatocellular carcinoma photothermal therapy treatment","volume":"10","author":"Ma","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.actbio.2022.11.001_bib0076","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ab.2009.07.027","article-title":"An adhesion-based method for plasma membrane isolation: evaluating cholesterol extraction from cells and their membranes","volume":"394","author":"Bezrukov","year":"2009","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.actbio.2022.11.001_bib0077","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.7150\/thno.20118","article-title":"Preparation and application of cell membrane-camouflaged nanoparticles for cancer therapy","volume":"7","author":"Zhai","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.actbio.2022.11.001_bib0078","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/biom10010048","article-title":"Engineering extracellular vesicles as nanotherapeutics for regenerative medicine","volume":"10","author":"Ramasubramanian","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.actbio.2022.11.001_bib0079","doi-asserted-by":"crossref","first-page":"7738","DOI":"10.1021\/acsnano.6b03148","article-title":"Liposomes coated with isolated macrophage membrane can target lung metastasis of breast cancer","volume":"10","author":"Cao","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.actbio.2022.11.001_bib0080","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejpb.2022.06.014","article-title":"Biomimetic nanotherapeutics\u00a0: employing nanoghosts to fight melanoma","volume":"177","author":"Bagasariya","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.actbio.2022.11.001_bib0081","doi-asserted-by":"crossref","DOI":"10.1101\/pdb.prot083436","article-title":"Homogenization of mammalian cells","volume":"2015","author":"de Ara\u00fajo","year":"2015","journal-title":"Cold Spring Harb. Protoc."},{"key":"10.1016\/j.actbio.2022.11.001_bib0082","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.tibtech.2009.04.004","article-title":"Advances in product release strategies and impact on bioprocess design","volume":"27","author":"Balasundaram","year":"2009","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.actbio.2022.11.001_bib0083","first-page":"2017","article-title":"Nitrogen cavitation and differential centrifugation allows for monitoring the distribution of peripheral membrane proteins in cultured cells","author":"Zhou","year":"2017","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.actbio.2022.11.001_bib0084","doi-asserted-by":"crossref","DOI":"10.1101\/pdb.prot5513","article-title":"Disruption of cultured cells by nitrogen cavitation","volume":"2010","author":"Simpson","year":"2010","journal-title":"Cold Spring Harb. Protoc."},{"key":"10.1016\/j.actbio.2022.11.001_bib0085","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1083\/jcb.86.1.21","article-title":"Neutrophil plasma membranes. I. High-yield purification of human neutrophil plasma membrane vesicles by nitrogen cavitation and differential centrifugation","volume":"86","author":"Klempner","year":"1980","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.actbio.2022.11.001_bib0086","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1021\/acsnano.7b00133","article-title":"Microfluidic electroporation-facilitated synthesis of erythrocyte membrane-coated magnetic nanoparticles for enhanced imaging-guided cancer therapy","volume":"11","author":"Rao","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.actbio.2022.11.001_bib0087","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2217\/nnm-2019-0388","article-title":"Cell membrane-coated nanoparticles: research advances","volume":"15","author":"Zou","year":"2020","journal-title":"Nanomedicine"},{"key":"10.1016\/j.actbio.2022.11.001_bib0088","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1016\/j.apsb.2022.02.023","article-title":"Cell membrane coated-nanoparticles for cancer immunotherapy","volume":"12","author":"Zeng","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.actbio.2022.11.001_bib0089","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s12951-022-01475-w","article-title":"Cell membrane-camouflaged inorganic nanoparticles for cancer therapy","volume":"20","author":"Song","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.actbio.2022.11.001_bib0090","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1002\/smll.201500987","article-title":"Synthesis of nanogels via cell membrane-templated polymerization","volume":"11","author":"Zhang","year":"2015","journal-title":"Small"},{"key":"10.1016\/j.actbio.2022.11.001_bib0091","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201706759","article-title":"Cell membrane coating nanotechnology","volume":"30","author":"Fang","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.actbio.2022.11.001_bib0092","first-page":"139","article-title":"Techniques for analysis of proteins by SDS-polyacrylamide gel electrophoresis and Western blotting","volume":"273","author":"Gibbins","year":"2004","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.actbio.2022.11.001_bib0093","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/bmb.21516","article-title":"Applications of western blot technique: from bench to bedside","volume":"49","author":"Meftahi","year":"2021","journal-title":"Biochem. Mol. Biol. Educ."},{"key":"10.1016\/j.actbio.2022.11.001_bib0094","article-title":"Expandable immunotherapeutic nanoplatforms engineered from cytomembranes of hybrid cells derived from cancer and dendritic cells","volume":"31","author":"Liu","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.actbio.2022.11.001_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2018.00113","article-title":"Neutrophil: a cell with many roles in inflammation or several cell types?","volume":"9","author":"Rosales","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.actbio.2022.11.001_bib0096","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41423-021-00832-3","article-title":"Neutrophils in chronic inflammatory diseases","volume":"19","author":"Herrero-Cervera","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.actbio.2022.11.001_bib0097","doi-asserted-by":"crossref","first-page":"7663","DOI":"10.2147\/IJN.S328705","article-title":"The advances of neutrophil-derived effective drug delivery systems: a key review of managing tumors and inflammation","volume":"16","author":"Wang","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.actbio.2022.11.001_bib0098","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201706245","article-title":"Neutrophil-based drug delivery systems HHS public access","volume":"30","author":"Chu","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.actbio.2022.11.001_bib0099","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107624","article-title":"Biodegradable hypocrellin B nanoparticles coated with neutrophil membranes for hepatocellular carcinoma photodynamics therapy effectively via JUNB\/ROS signaling","volume":"99","author":"Zhang","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.actbio.2022.11.001_bib0100","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","article-title":"Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review","volume":"65","author":"Maeda","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2022.11.001_bib0101","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.actbio.2022.11.001_bib0102","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.2147\/IJN.S244849","article-title":"Paclitaxel-loaded macrophage membrane camouflaged albumin nanoparticles for targeted cancer therapy","volume":"15","author":"Cao","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.actbio.2022.11.001_bib0103","doi-asserted-by":"crossref","first-page":"56767","DOI":"10.1021\/acsami.0c17235","article-title":"Macrophage-membrane-camouflaged disintegrable and excretable nanoconstruct for deep tumor penetration","volume":"12","author":"Poudel","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.actbio.2022.11.001_bib0104","series-title":"Biomed. Pharmacother.","first-page":"124","article-title":"Cancer immunotherapy: pros, cons and beyond","author":"Tan","year":"2020"},{"key":"10.1016\/j.actbio.2022.11.001_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/adma.202003368","article-title":"T-cell-mimicking nanoparticles for cancer immunotherapy","volume":"32","author":"Kang","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.actbio.2022.11.001_bib0106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-022-03402-z","article-title":"Infiltrating natural killer cells bind, lyse and increase chemotherapy efficacy in glioblastoma stem-like tumorospheres","volume":"5","author":"Breznik","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.actbio.2022.11.001_bib0107","doi-asserted-by":"crossref","first-page":"11452","DOI":"10.1021\/acsnano.0c03824","article-title":"Natural-killer-cell-inspired nanorobots with aggregation-induced emission characteristics for near-infrared-II fluorescence-guided glioma theranostics","volume":"14","author":"Deng","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.actbio.2022.11.001_bib0108","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.biomaterials.2018.01.018","article-title":"Natural killer cell membrane infused biomimetic liposomes for targeted tumor therapy","volume":"160","author":"Pitchaimani","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2022.11.001_bib0109","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.3389\/fimmu.2019.01719","article-title":"T cell dysfunction in cancer immunity and immunotherapy","volume":"10","author":"Xia","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actbio.2022.11.001_bib0110","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3390\/cancers13010077","article-title":"Immunocyte membrane-coated nanoparticles for cancer immunotherapy","volume":"13","author":"Gong","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.actbio.2022.11.001_bib0111","doi-asserted-by":"crossref","first-page":"8340","DOI":"10.3390\/ijms22158340","article-title":"Dendritic cells and CCR7 expression: an important factor for autoimmune diseases, chronic inflammation, and cancer","volume":"22","author":"Brandum","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.actbio.2022.11.001_bib0112","first-page":"279","article-title":"Intelligent photothermal dendritic cells restart the cancer immunity cycle through enhanced immunogenic cell death","author":"Sun","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2022.11.001_bib0113","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1021\/acs.biomac.0c00518","article-title":"pH-responsive biomimetic polymeric micelles as lymph node-targeting vaccines for enhanced antitumor immune responses","volume":"21","author":"Yang","year":"2020","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.actbio.2022.11.001_bib0114","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.2217\/nnm.15.111","article-title":"Nanoparticle-mediated drug delivery for treating melanoma","volume":"10","author":"Mundra","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.actbio.2022.11.001_bib0115","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202102330","article-title":"Engineered cell membrane-derived nanoparticles in immune modulation","volume":"8","author":"Yang","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.actbio.2022.11.001_bib0116","doi-asserted-by":"crossref","first-page":"9010","DOI":"10.1073\/pnas.0901329106","article-title":"Impaired interferon signaling is a common immune defect in human cancer","volume":"106","author":"Critchley-Thorne","year":"2009","journal-title":"Proc. Natl. Acad. Sci"},{"key":"10.1016\/j.actbio.2022.11.001_bib0117","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41422-020-0343-4","article-title":"Immune checkpoint signaling and cancer immunotherapy","volume":"30","author":"He","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.actbio.2022.11.001_bib0118","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nri3845","article-title":"Type I interferons in anticancer immunity","volume":"15","author":"Zitvogel","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.actbio.2022.11.001_bib0119","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/s41565-021-00972-7","article-title":"T lymphocyte membrane-decorated epigenetic nanoinducer of interferons for cancer immunotherapy","volume":"16","author":"Zhai","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.actbio.2022.11.001_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2021.770561","article-title":"Immunosuppression in glioblastoma: current understanding and therapeutic implications","volume":"11","author":"Himes","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.actbio.2022.11.001_bib0121","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.3390\/cancers13153686","article-title":"Recent advances in glioma therapy: combining vascular normalization and immune checkpoint blockade","volume":"13","author":"Ho","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.actbio.2022.11.001_bib0122","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.1021\/acs.nanolett.2c01863","article-title":"Engineered macrophage-membrane-coated nanoparticles with enhanced PD-1 expression induce immunomodulation for a synergistic and targeted antiglioblastoma activity","volume":"22","author":"Yin","year":"2022","journal-title":"Nano Lett."},{"key":"10.1016\/j.actbio.2022.11.001_bib0123","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s13238-016-0367-1","article-title":"T-cell receptor-engineered T cells for cancer treatment: current status and future directions","volume":"9","author":"Ping","year":"2018","journal-title":"Protein Cell"},{"key":"10.1016\/j.actbio.2022.11.001_bib0124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2020.05.028","article-title":"Hybrid cell membrane-coated nanoparticles: a multifunctional biomimetic platform for cancer diagnosis and therapy","volume":"112","author":"Chen","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2022.11.001_bib0125","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1021\/acs.biomac.1c00440","article-title":"Hybrid membrane-coated biomimetic nanoparticles (HM@BNPs): a multifunctional nanomaterial for biomedical applications","volume":"22","author":"Zhao","year":"2021","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.actbio.2022.11.001_bib0126","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1021\/acs.nanolett.8b01892","article-title":"Leutusome: a biomimetic nanoplatform integrating plasma membrane components of leukocytes and tumor cells for remarkably enhanced solid tumor homing","volume":"18","author":"He","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.actbio.2022.11.001_bib0127","first-page":"3865","article-title":"Leukocyte\/platelet hybrid membrane-camouflaged dendritic large pore mesoporous silica nanoparticles co-loaded with photo\/chemotherapeutic agents for triple negative breast cancer combination treatment","volume":"6","author":"Zhang","year":"2021","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.actbio.2022.11.001_bib0128","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201909781","article-title":"Multivalent aptamer functionalized Ag 2 S nanodots\/hybrid cell membrane-coated magnetic nanobioprobe for the ultrasensitive isolation and detection of circulating tumor cells","volume":"30","author":"Ding","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.actbio.2022.11.001_bib0129","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1111\/cas.13697","article-title":"Exosomes in cancer development and clinical applications","volume":"109","author":"Tai","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.actbio.2022.11.001_bib0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120210","article-title":"Enigmatic role of exosomes in breast cancer progression and therapy","volume":"289","author":"Famta","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.actbio.2022.11.001_bib0131","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12964-021-00730-1","article-title":"The exosome journey: from biogenesis to uptake and intracellular signalling","volume":"19","author":"Gurung","year":"2021","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.actbio.2022.11.001_bib0132","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.4161\/onci.20897","article-title":"Dendritic cell exosomes directly kill tumor cells and activate natural killer cells via TNF superfamily ligands","volume":"1","author":"Munich","year":"2012","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.actbio.2022.11.001_bib0133","article-title":"Engineered neutrophil-derived exosome-like vesicles for targeted cancer therapy","volume":"8","author":"Zhang","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.actbio.2022.11.001_bib0134","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/CJI.0000000000000179","article-title":"NK Cell\u2013derived exosomes from NK Cells previously exposed to neuroblastoma cells augment the antitumor activity of cytokine-activated NK Cells","volume":"40","author":"Shoae-Hassani","year":"2017","journal-title":"J. Immunother."},{"key":"10.1016\/j.actbio.2022.11.001_bib0135","first-page":"1","article-title":"The effects of tumor-derived exosomes on T-cell function and efficacy of cancer immunotherapy","author":"Hao","year":"2021","journal-title":"ImmunoMedicine"},{"key":"10.1016\/j.actbio.2022.11.001_bib0136","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12951-021-00922-4","article-title":"Biomimetic nanotherapy: core\u2013shell structured nanocomplexes based on the neutrophil membrane for targeted therapy of lymphoma","volume":"19","author":"Zhao","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.actbio.2022.11.001_bib0137","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1080\/02656736.2022.2093994","article-title":"Neutrophil membrane-coated nanoparticles for enhanced nanosecond pulsed electric field treatment of pancreatic cancer","volume":"39","author":"Zhao","year":"2022","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.actbio.2022.11.001_bib0138","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.biomaterials.2019.04.026","article-title":"Scaffolds biomimicking macrophages for a glioblastoma NIR-Ib imaging guided photothermal therapeutic strategy by crossing Blood-Brain Barrier","volume":"211","author":"Lai","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2022.11.001_bib0139","doi-asserted-by":"crossref","first-page":"12096","DOI":"10.1021\/acsnano.8b05292","article-title":"Cell-membrane immunotherapy based on natural killer cell membrane coated nanoparticles for the effective inhibition of primary and abscopal tumor growth","volume":"12","author":"Deng","year":"2018","journal-title":"ACS Nano"},{"issue":"14","key":"10.1016\/j.actbio.2022.11.001_bib0140","first-page":"1","article-title":"NK cell-based cancer immunotherapy: from basic biology to clinical development","volume":"141","author":"Liu","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.actbio.2022.11.001_bib0141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2018.00790","article-title":"Current trends and challenges in the clinical translation of nanoparticulate nanomedicines: pathways for translational development and commercialization","volume":"9","author":"Hua","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.actbio.2022.11.001_bib0142","series-title":"Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use Guidance for Industry and Food and Drug Administration Staff Contains Nonbinding Recommendations Regulatory Considerations","year":"2020"},{"key":"10.1016\/j.actbio.2022.11.001_bib0143","first-page":"13","article-title":"Quality by design (QbD): a new concept for development of quality pharmaceuticals","volume":"4","author":"Patil","year":"2013","journal-title":"Int. J. Pharm. Qual. Assur."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706122007267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706122007267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:03:38Z","timestamp":1761674618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706122007267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":143,"alternative-id":["S1742706122007267"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2022.11.001","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune cell\u2013camouflaged surface-engineered nanotherapeutics for cancer management","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2022.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}